Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Dynavax Technologies Corporation (DVAX)

« Back to company index

DVAX Chatter Timeline

Stock Ticker for DVAX

Most Active Tweeters for DVAX

UserTweets
@MaisaCorp 5
@AmericanBanking 4
@TopStockAlerts1 4
@bulletin_en 4
@1MinuteStock 4

Recent Tweets for DVAX

dbuello @dbuello
All out of $DVAX, Add it to a long list of success followed quickly by failure. Quickly learning that while gaining… https://t.co/2dcVLOvcut
May 23rd 2019, 8:05pm
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $DVAX is $-0.17 it's -2.67% of the current price https://t.co/O6sAzMid9J
May 23rd 2019, 7:05pm
Bigapple2la @Bigapple2la
$DVAX finally admits SD-101 melanoma data was a bust, kind of.
May 23rd 2019, 7:05pm
Sanctuary_Bio @Sanctuary_Bio
In light of $DVAX update, remember this Gl if you are in this name https://t.co/D2w5q1VHEE
May 23rd 2019, 7:05pm
Briefingcom @Briefingcom
$DVAX: Dynavax announces restructuring; will explore strategic alternatives for immuno-oncology programs; CEO to... https://t.co/aTIl25wjFh
May 23rd 2019, 6:05pm
StockMatusow @StockMatusow
@TheRealANC However, make your fundamental case, WHY will the $DVAX ship turn around specifically? Not what you hop… https://t.co/A8qbt04mV0
May 23rd 2019, 6:05pm
MarketChmln @MarketChmln
$DVAX #DynavaxTechnologies declines in after hours trading. See the latest news. https://t.co/PIFUgBpFa0 https://t.co/wy3jef7UkG
May 23rd 2019, 6:05pm
MarketCurrents @MarketCurrents
$DVAX - Dynavax to focus on vaccines; CEO retires; shares -7.9% https://t.co/IyMzGUj2Nr
May 23rd 2019, 6:05pm
dhovekamp42 @dhovekamp42
RT @zbiotech: $DVAX restructuring, cuts 37% of workforce CEO to 'retire' exploring options for SD-101, focus on vaccine
May 23rd 2019, 6:05pm
The_Squibb @The_Squibb
With the overpaid, non-performing CEO gone, along with the oncology money pit, this just as much positive as it is negative. $DVAX
May 23rd 2019, 6:05pm
StockMatusow @StockMatusow
@ANACONDAFINANC1 @TheBestCybers The best-laid plans of mice and men often go awry :) $DVAX
May 23rd 2019, 5:05pm
Allstocknews @Allstocknews
$DVAX New Form DEFA14A for Dynavax Technologies Corporation From our Stock News Alerts App
May 23rd 2019, 5:05pm
RSIDayTrader @RSIDayTrader
$DVAX bk soon enough
May 23rd 2019, 5:05pm
CHItraders @CHItraders
$DVAX Dynavax announces layoffs, CEO retirement - MarketWatch https://t.co/90RayRl63t)
May 23rd 2019, 5:05pm
bs2537 @bs2537
$DVAX decision to divest SD-101, bad news for similar private companies likle Checkmate Pharmaceuticals. (no positi… https://t.co/JeMTQMQB7Y
May 23rd 2019, 5:05pm
MaisaCorp @MaisaCorp
$DVAX summary: Company will explore strategic alternatives for its immuno-oncology programs Eddie Gray, CEO,… https://t.co/iqQvDXrYHD
May 23rd 2019, 5:05pm
MaisaCorp @MaisaCorp
$DVAX resumes
May 23rd 2019, 5:05pm
MaisaCorp @MaisaCorp
$DVAX As of March 31, 2019, the company reported cash, cash equivalents and marketable securities totaling $183.2 million.
May 23rd 2019, 5:05pm
MaisaCorp @MaisaCorp
$DVAX The company’s board of directors has created an interim Office of the President and has appointed David Nov… https://t.co/NVU2eYO64d
May 23rd 2019, 5:05pm
MaisaCorp @MaisaCorp
$DVAX As a result, the board and management have made the difficult decision to reduce our workforce. We want to… https://t.co/T7A77AD8ac
May 23rd 2019, 5:05pm
BioRunUp @BioRunUp
RT @TraderTexMex: $DVAX Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business
May 23rd 2019, 5:05pm
gcbioinv @gcbioinv
$DVAX restructuring to focus on Heplisav, exploring strategics for immunooncology assets
May 23rd 2019, 5:05pm
funstocks1 @funstocks1
@zerosum24 $DVAX Wonder anyone will be interested in #SD101 aka #TLR9 agonist that lacks single agent activity yet… https://t.co/V57vWnUhxn
May 23rd 2019, 5:05pm
PredatorDiaries @PredatorDiaries
@TraderTexMex After a job well done. Sorry Eddie, we met when we were both at SmithKline, but $DVAX was a different gig
May 23rd 2019, 4:05pm
zerosum24 @zerosum24
$DVAX another biotech disaster
May 23rd 2019, 4:05pm
zerosum24 @zerosum24
$DVAX - UPDATE: Dynavax Says Will Reduce Co. Workforce, Operations To Focus Resources On HEPLISAV-B Commercialization
May 23rd 2019, 4:05pm
zerosum24 @zerosum24
$DVAX - Dynavax To Restructure to Prioritize Its Vaccine Unit By Focusing Co.'s First Commercial Product HEPLISAV-B
May 23rd 2019, 4:05pm
zerosum24 @zerosum24
$DVAX Dynavax Reports Co. Will Explore Strategic Alternatives For Its Immuno-Oncology Programs..
May 23rd 2019, 4:05pm
Drchik23 @Drchik23
$DVAX Dynavax Announced Strategic Restructuring to Focus on its Vaccine Business. CEO retiring. Halted until 5:15.
May 23rd 2019, 4:05pm
StockTexts @StockTexts
$DVAX Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business Nasdaq:DVAX https://t.co/b64JfomZQd
May 23rd 2019, 4:05pm
LargeVoidBot @LargeVoidBot
$DVAX Will resume 17:15:00. News and Resumption Times. (Halted: 16:42:49)
May 23rd 2019, 4:05pm
Allstocknews @Allstocknews
$DVAX Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business From our Stock News Alerts App
May 23rd 2019, 4:05pm
StockMatusow @StockMatusow
Congrats $DVAX, you just assured your stock is going the $SGYP route. = ZERO #Biotech - yet another mismanaged TURD… https://t.co/ES6xuKIrBG
May 23rd 2019, 4:05pm
zbiotech @zbiotech
$DVAX restructuring, cuts 37% of workforce CEO to 'retire' exploring options for SD-101, focus on vaccine
May 23rd 2019, 4:05pm
LargeVoidBot @LargeVoidBot
$DVAX Halt - News Released. Halt time: 16:42:49.
May 23rd 2019, 4:05pm
TraderTexMex @TraderTexMex
$DVAX CEO retiring
May 23rd 2019, 4:05pm
TraderTexMex @TraderTexMex
$DVAX Dynavax Announces Strategic Restructuring to Focus on its Vaccine Business
May 23rd 2019, 4:05pm
SudhanvaRaj @SudhanvaRaj
RT @RTFilingsStocks: $DVAX halted News Pending
May 23rd 2019, 4:05pm
StockHaltBot @StockHaltBot
HALTED: $DVAX Date: 2019-05-23 Time: 16:42:49 Code: T1
May 23rd 2019, 4:05pm
RTFilingsStocks @RTFilingsStocks
$DVAX halted News Pending
May 23rd 2019, 4:05pm
LargeVoidBot @LargeVoidBot
$DVAX Halt - News Pending. Halt time: 16:42:49.
May 23rd 2019, 4:05pm
Tickeron @Tickeron
$DVAX Dynavax Technologies (DVAX, $6.55) was this quarter's top loser, falling -40% https://t.co/pzn3CL8Zy0
May 22nd 2019, 10:05pm
Tickeron @Tickeron
$DVAX Dynavax Technologies (DVAX, $6.55) was the market's top winner yesterday, jumping +8.62% https://t.co/LGIL0jRlWo
May 22nd 2019, 12:05pm
Tickeron @Tickeron
$DVAX Dynavax Technologies (DVAX, $6.03) was this quarter's top loser, falling -45% https://t.co/BMMVWB5eFd
May 21st 2019, 10:05pm
WalterBriBri @WalterBriBri
@scientwest Or does that decrease the percentage of success for SD-101? I can see it both ways. I'd rather $DVAX be… https://t.co/Spp7FgpOEU
May 21st 2019, 6:05pm
SwingTradeBot @SwingTradeBot
Recent $DVAX technical alerts: New 52 Week Low plus 4 more alerts... https://t.co/f3bAAYyT8w
May 21st 2019, 10:05am
biotechw2019 @biotechw2019
$DVAX $6 gap now fully filled https://t.co/Vfnr2u3KDL
May 21st 2019, 8:05am
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $DVAX? The Short Ratio is 16.4% https://t.co/C1FO0ImLZV
May 21st 2019, 6:05am
1MinuteStock @1MinuteStock
Not sure what to do with $DVAX? Explore our #fundamental pros and cons. https://t.co/PsFarBIaGV
May 21st 2019, 6:05am
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $DVAX for you: -2.86% https://t.co/fbnYIomKvo
May 21st 2019, 5:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.